Abstract:BackgroundFanconi anemia (FA) is a rare genetic disorder characterized by congenital anomalies, progressive bone marrow failure and high susceptibility to various solid tumors, especially head and neck squamous cell carcinoma (HNSCC). Management of FA patients with head and neck cancer is a challenge due to increased risk of surgery, poor tolerance of chemotherapy, and severe myelotoxicity of radiotherapy.MethodsWe present a case of a 33-year-old man with carcinoma of the oral tongue (T1N2M0), who experienced prolonged and profound bone marrow failure as a consequence of concurrent cisplatin/radiation. The young patient who developed HNSCC without risk factors, the myelotoxicity after exposure to the platinum-based agent cisplatin and the further evaluation of phenotypic characteristics raised suspicion of FA. Whole exome sequencing performed for the patient and parents ultimately established the diagnosis of FA.ResultsGenetic testing in the 23 FANC genes revealed two novel heterozygous mutations, c.367C>T (p.Gln123*) and c.3971_3972delCGinsTT (p.Pro13241.cu) in FANCA gene of the patient, which were inherited from his father and mother, respectively. Radiotherapy with reduced dose has successfully alleviated the symptoms of tumor invasion and progression, and the radiation-related side effects were acceptable. Unfortunately, the patient died of locoregional disease progression.ConclusionsThis case highlights the importance of considering the diagnosis of FA in young patients who develop HNSCC in the absence of risk factors, thus permitting more effective oncological treatment strategies and improved outcomes. In general, any decision on different modalities of management in such patients should be based on a balance between locoregional control and therapeutic toxicity.

The Importance Of Oral Cavity Surveillance In Patients With Fanconi Anemia For Early Diagnosis Of Oral Cancer.

Oral Squamous Cell Carcinoma In Fanconi Anemia: Case Report.

Oral Cancer In A Patient With Fanconi Anemia, 28 Years After Hematopoietic Stem Cell Transplantation: Case Report.

Oral Tongue Cancer in a Patient with Fanconi Anemia: A Case Report and Literature Review

A Case Series: Cancer In Buccal Mucosa In Patients With Fanconi Anemia.

Oral Premalignant and Malignant Lesions in Fanconi Anemia Patients

Diagnosis and Treatment for Squamous Cell Carcinoma of the Oral Tongue in a Patient with Fanconi Anemia

Oral health-related quality of life in Fanconi anemia: a cross-sectional study

Two enemies, one fight: An update of oral cancer in patients with Fanconi anemia

The Onset and Progression of Oral Potentially Malignant Disorders in Fanconi Anemia Patients: Highlighting Early Detection of Oral Cancer

Frequency Of Micronuclei In Oral Epithelial Cells From Patients With Fanconi Anemia.

S701 Endoscopic Findings and Intervention Outcomes in Patients With Fanconi Anemia and Esophageal Dysplasia

Clinical and Genetic Spectrum of Fanconi Anaemia in Australia and New Zealand.

Longitudinal clinical manifestations of Fanconi anemia: A systematized review

Epidemiological Profile Of Patients With Fanconi Anemia In Follow-Up In A Public Hospital In The South Of Brazil.

Benign tumors and non-melanoma skin cancers in patients with Fanconi anemia

Multiples Primary Oral Squamous Cell Carcinomas After Allogeneic Bone Marrow Transplantation In Fanconi Anemia

Fanconi Anemia in a 31-Year-Old Patient with Multiple Malignant Tumor Foci, Including Appendiceal Cancer, and Multiple Coexisting Pathologies

Oropharyngeal carcinoma in fanconi anemia patient - Radiation treatment, toxicity, and a year follow-up: Case report

Oral Leukoplakia in Adolescents: Attention to Differential Diagnosis of Inherited Genetic Syndromes with Emphasis on Dyskeratosis Congenita and Fanconi Anemia

Evaluation of inherited cancer syndromes with emphasis on Fanconi anemia classified as oral potentially malignant disorders.